Description: Our lab is focused on developing genome editing technologies as safe and effective therapies for human genetic conditions such as sickle cell disease.
for (30) editing (14) technologies (6) genome (3) therapeutics (1)
TSAI LAB St. Jude Children's Research Hospital Developing genome editing technologies as safe and effective therapies for human genetic conditions such as sickle cell disease.
In the Tsai lab, our long-term goal is to advance safe and effective genome editing technologies to treat hematological conditions from bench to the bedside. Our current projects include:
Protein engineering of CRISPR-Cas genome editors with improved activity, specificity, and precise control of DNA repair outcomes.